Home » Topics » Regulatory, BioWorld Science

Regulatory, BioWorld Science
RSS

FDA approves Nexletol to lower LDL-C in patients with HeFH or ASCVD

Feb. 24, 2020

Neoral approved for acute stage Kawasaki disease in Japan

Feb. 24, 2020

Opdivo approved in Japan for advanced esophageal cancer

Feb. 21, 2020

Saroglitazar approved in India as add on treatment for type 2 diabetes

Feb. 5, 2020

FDA approves Audenz to protect against influenza A (H5N1)

Feb. 4, 2020

FDA approves Palforzia oral immunotherapy for peanut allergy

Feb. 3, 2020

Erleada receives extended approval in Europe for metastatic hormone-sensitive prostate cancer

Jan. 30, 2020

FDA approves Trijardy XR for type 2 diabetes

Jan. 28, 2020

Anerem approved in Japan for general anesthesia

Jan. 24, 2020

Japanese approval for Corectim ointment for atopic dermatitis

Jan. 24, 2020

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...